14. 在协委会第 43 次会议上，报告了某份协委会文件在以下方面的发现：如何支持中低收入国家消除获取途径方面的障碍，包括知识产权相关障碍，以及哪些因素会影响对艾滋病及其合并感染和并发症卫生技术的获取和承担能力。文件强调，将近一半的艾滋病毒携带者仍然无法获取治疗，而且儿童的治疗覆盖率低于成人。大多数艾滋病毒携带者生活在中等收入国家，这些国家大多未被纳入自愿许可协议中，所以卫生商品价格非常高昂，而这类协议可以促进艾滋病毒相关药物和其他卫生技术的定价更容易负担得起。在尝试使用“与贸易有关的知识产权协定”时，各国经常遇到巨大难题，虽然当地生产规模正在扩大，但许多国家仍然难以获得价格亲民的抗逆转录病毒药物、丙型肝炎治疗服务和艾滋病暴露前预防服务。
14. The findings of a PCB paper on how low- and middle-income countries can be supported to overcome access barriers, including intellectual property-related barriers, and factors that affect the availability and affordability of health technologies for HIV and its co-infections and co-morbidities, were presented at the 43rd PCB meeting. The paper highlighted that almost half of PLHIV are still not accessing treatment, and that treatment coverage for children was lower than for adults. The majority of PLHIV now live in middle-income countries, the majority of which are not included in the voluntary licensing agreements that have facilitated more affordable pricing arrangements for HIV-related medicines and other health technologies, resulting in high prices for health commodities. Countries often encounter significant difficulties when trying to use the Trade-Related Aspects of Intellectual Property Rights agreement (TRIPS), and, though local production is expanding, many countries struggle to access affordable versions of antiretrovirals, treatment for hepatitis C and PrEP.